• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利乳腺癌负担的区域估计。

Regional estimates of breast cancer burden in Italy.

作者信息

Grande Enrico, Inghelmann Riccardo, Francisci Silvia, Verdecchia Arduino, Micheli Andrea, Baili Paolo, Capocaccia Riccardo, De Angelis Roberta

机构信息

Reparto di Epidemiologia dei Tumori, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanità, Rome, Italy.

出版信息

Tumori. 2007 Jul-Aug;93(4):374-9. doi: 10.1177/030089160709300408.

DOI:10.1177/030089160709300408
PMID:17899868
Abstract

AIMS AND BACKGROUND

Breast cancer is the most common cancer and the leading cause of cancer death among women. Knowledge of the present and future burden of the disease at a regional and national scale is a major issue in Italy, where the frequency and coverage of screening programs vary considerably across the country. This study presents estimates and projections of the female breast cancer incidence, prevalence and mortality for Italy and all Italian regions in the period 1970-2010.

METHODS

The estimates were obtained by applying the MIAMOD method, a statistical back-calculation approach to derive incidence and prevalence figures from mortality and relative survival data. Published data from the Italian cancer registries were modelled to obtain regional and national estimates of breast cancer survival.

RESULTS

Breast cancer mortality has been declining from the late 1980s in the northern-central regions and from the mid 1990s in the southern regions Puglia, Sicilia and Sardegna. Stable mortality rates are estimated for the other southern regions in the 2000's first decade. The incidence rate in Italy is estimated as increasing until the late 1990s, and stable thereafter (93 per 100,000). The incidence curve is also estimated to flatten in many northern-central regions from the late 1990s or later. Rising incidence trends are estimated in all southern regions, with the exception of Puglia. About 8,500 deaths, 37,000 new diagnoses and 416,000 prevalent cases for breast cancer are estimated among Italian women in 2005. In the same year, the proportion of prevalent cases in the northern area (1221 per 100,000) is about twice that estimated in the South (685 per 100,000).

DISCUSSION

The geographical variation in female breast cancer burden can be explained by the unequal distribution of screening. A more widespread screening activity in the southern regions would help to bridge the gap between northern-central and southern regions. Continuous monitoring of regional epidemiological indicators for breast cancer is crucial to evaluate the effect of different health measures taken to control breast cancer in Italy.

摘要

目的与背景

乳腺癌是女性中最常见的癌症,也是癌症死亡的主要原因。在意大利,了解该疾病在区域和国家层面当前及未来的负担是一个重大问题,因为该国筛查项目的频率和覆盖范围在全国范围内差异很大。本研究给出了1970 - 2010年期间意大利及所有意大利地区女性乳腺癌发病率、患病率和死亡率的估计值及预测值。

方法

这些估计值是通过应用MIAMOD方法获得的,这是一种从死亡率和相对生存数据推导发病率和患病率数字的统计反向计算方法。对意大利癌症登记处公布的数据进行建模,以获得乳腺癌生存率的区域和国家估计值。

结果

从20世纪80年代末起,意大利中北部地区的乳腺癌死亡率开始下降,而南部地区普利亚、西西里和撒丁岛从20世纪90年代中期起死亡率开始下降。预计在21世纪第一个十年,其他南部地区的死亡率保持稳定。意大利的发病率估计在20世纪90年代末之前呈上升趋势,此后保持稳定(每10万人中有93例)。许多中北部地区的发病率曲线预计从20世纪90年代末或更晚开始趋于平缓。除普利亚外,所有南部地区的发病率都呈上升趋势。2005年,估计意大利女性中有约8500例乳腺癌死亡、37000例新诊断病例和416000例现患病例。同年,北部地区的现患病例比例(每10万人中有1221例)约为南部地区(每10万人中有685例)的两倍。

讨论

女性乳腺癌负担的地理差异可以通过筛查分布不均来解释。在南部地区开展更广泛的筛查活动将有助于缩小中北部和南部地区之间的差距。持续监测乳腺癌的区域流行病学指标对于评估意大利为控制乳腺癌而采取的不同健康措施的效果至关重要。

相似文献

1
Regional estimates of breast cancer burden in Italy.意大利乳腺癌负担的区域估计。
Tumori. 2007 Jul-Aug;93(4):374-9. doi: 10.1177/030089160709300408.
2
Regional estimates of all cancer malignancies in Italy.意大利所有癌症恶性肿瘤的区域估计数。
Tumori. 2007 Jul-Aug;93(4):345-51. doi: 10.1177/030089160709300404.
3
Regional estimates of prostate cancer burden in Italy.意大利前列腺癌负担的区域估计。
Tumori. 2007 Jul-Aug;93(4):380-6. doi: 10.1177/030089160709300409.
4
Regional estimates of colorectal cancer burden in Italy.意大利结直肠癌负担的区域估计。
Tumori. 2007 Jul-Aug;93(4):352-9. doi: 10.1177/030089160709300405.
5
Regional estimates of lung cancer burden in Italy.
Tumori. 2007 Jul-Aug;93(4):360-6. doi: 10.1177/030089160709300406.
6
Regional estimates of stomach cancer burden in Italy.意大利胃癌负担的区域估计。
Tumori. 2007 Jul-Aug;93(4):367-73. doi: 10.1177/030089160709300407.
7
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
8
Estimates of cancer burden in Piedmont and Aosta Valley.皮埃蒙特和瓦莱达奥斯塔癌症负担估计数。
Tumori. 2013 May-Jun;99(3):269-76. doi: 10.1177/030089161309900301.
9
Estimates of cancer burden in Umbria.翁布里亚癌症负担的估计。
Tumori. 2013 May-Jun;99(3):342-50. doi: 10.1177/030089161309900309.
10
Italian cancer burden by broad geographical area.意大利按广泛地理区域划分的癌症负担。
Tumori. 2007 Jul-Aug;93(4):398-407. doi: 10.1177/030089160709300412.

引用本文的文献

1
Survival of Breast Cancer by Stage, Grade and Molecular Groups in Mallorca, Spain.西班牙马略卡岛乳腺癌按分期、分级和分子分型的生存率
J Clin Med. 2022 Sep 27;11(19):5708. doi: 10.3390/jcm11195708.
2
Study of Inflammatory and Infection Markers in Periprosthetic Fluid: Correlation with Blood Analysis in Retrospective and Prospective Studies.关节假体周围液中炎症和感染标志物的研究:回顾性和前瞻性研究中与血液分析的相关性。
Biomed Res Int. 2021 Mar 19;2021:6650846. doi: 10.1155/2021/6650846. eCollection 2021.
3
Diagnostic and therapeutic path of breast cancer: effectiveness, appropriateness, and costs--results from the DOCMa study.
乳腺癌的诊断与治疗路径:有效性、适宜性及成本——DOCMa研究结果
Clin Interv Aging. 2015 Apr 17;10:741-9. doi: 10.2147/CIA.S75486. eCollection 2015.
4
The burden of breast cancer from China to Italy.从中国到意大利的乳腺癌负担。
J Thorac Dis. 2014 Jun;6(6):591-4. doi: 10.3978/j.issn.2072-1439.2014.06.21.
5
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study.一项关于紫杉醇白蛋白(纳米白蛋白结合型紫杉醇)与传统紫杉醇用于转移性乳腺癌患者的意大利成本效益分析:COSTANza研究
Clinicoecon Outcomes Res. 2013 Apr 11;5:125-35. doi: 10.2147/CEOR.S41850. Print 2013.
6
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study.pT1a 和 pT1b 乳腺癌的辅助化疗:来自 NEMESI 研究的结果。
BMC Cancer. 2012 Apr 30;12:158. doi: 10.1186/1471-2407-12-158.
7
Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer.评估 HER2 和 p53 表达在预测晚期乳腺癌患者对基于多西紫杉醇的一线化疗反应中的作用。
J Exp Clin Cancer Res. 2011 Apr 11;30(1):38. doi: 10.1186/1756-9966-30-38.
8
Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005.意大利乳腺癌发病率:2000年至2005年间实施的乳房切除术和象限切除术。
J Exp Clin Cancer Res. 2009 Jun 19;28(1):86. doi: 10.1186/1756-9966-28-86.
9
Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy.细胞周期蛋白E与锰超氧化物歧化酶表达相关,并可预测接受以表柔比星为基础的辅助化疗的早期乳腺癌患者的生存率。
Cancer Sci. 2009 Jun;100(6):1026-33. doi: 10.1111/j.1349-7006.2009.01141.x. Epub 2009 Mar 31.